Pharma, Biotech & CDMO
Senior Quality support for organizations operating under GxP expectations where weak evidence, ineffective CAPA or poor governance can quickly become business risk.
Where We Help
CAPA, investigations, change control, supplier quality, data integrity, audit and inspection readiness, validation, computerized systems, annual product review, remediation, deviation management and scalable Quality governance.
The Decision We Protect
Whether the evidence demonstrates a controlled system and whether remediation or governance decisions can be defended to customers, auditors and regulators without creating unnecessary bureaucracy.